Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 4
2006 2
2007 4
2008 5
2009 4
2010 4
2011 2
2012 6
2013 2
2014 6
2015 6
2016 2
2017 3
2018 1
2019 5
2020 5
2021 2
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Myeloid malignancies: mutations, models and management.
Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, Birnbaum D. Murati A, et al. BMC Cancer. 2012 Jul 23;12:304. doi: 10.1186/1471-2407-12-304. BMC Cancer. 2012. PMID: 22823977 Free PMC article. Review.
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.
Luque Paz D, Jouanneau-Courville R, Riou J, Ianotto JC, Boyer F, Chauveau A, Renard M, Chomel JC, Cayssials E, Gallego-Hernanz MP, Pastoret C, Murati A, Courtier F, Rousselet MC, Quintin-Roué I, Cottin L, Orvain C, Thépot S, Chrétien JM, Delneste Y, Ifrah N, Blanchet O, Hunault-Berger M, Lippert E, Ugo V. Luque Paz D, et al. Among authors: murati a. Blood Adv. 2020 Oct 13;4(19):4887-4897. doi: 10.1182/bloodadvances.2020002271. Blood Adv. 2020. PMID: 33035330 Free PMC article.
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
Petit C, Saillard C, Mohty B, Hicheri Y, Villetard F, Maisano V, Charbonnier A, Rey J, D'Incan E, Rouzaud C, Gelsi-Boyer V, Murati A, Lhoumeau AC, Ittel A, Mozziconacci MJ, Alary AS, Hospital MA, Vey N, Garciaz S. Petit C, et al. Among authors: murati a. Eur J Haematol. 2024 Apr;112(4):530-537. doi: 10.1111/ejh.14140. Epub 2023 Nov 29. Eur J Haematol. 2024. PMID: 38031389
Parental thoughts after the Codroipo case: the other side of the story.
Brunelli L, Romanese F, Tricarico P, Murati A, Benetollo PP, Iob A, Forgiarini M, Valent F, Brusaferro S. Brunelli L, et al. Among authors: murati a. Ann Ig. 2022 May-June;34(3):279-285. doi: 10.7416/ai.2021.2481. Epub 2021 Oct 11. Ann Ig. 2022. PMID: 34623370 Free article.
Gains of EPOR and ERG genes in adult erythroleukaemia.
Adélaïde J, Cervera N, Guille A, Murati A, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D, Gelsi-Boyer V. Adélaïde J, et al. Among authors: murati a. Br J Haematol. 2020 May;189(4):e174-e177. doi: 10.1111/bjh.16586. Epub 2020 Mar 29. Br J Haematol. 2020. PMID: 32227335 Free article. No abstract available.
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
Luque Paz D, Riou J, Verger E, Cassinat B, Chauveau A, Ianotto JC, Dupriez B, Boyer F, Renard M, Mansier O, Murati A, Rey J, Etienne G, Mansat-De Mas V, Tavitian S, Nibourel O, Girault S, Le Bris Y, Girodon F, Ranta D, Chomel JC, Cony-Makhoul P, Sujobert P, Robles M, Ben Abdelali R, Kosmider O, Cottin L, Roy L, Sloma I, Vacheret F, Wemeau M, Mossuz P, Slama B, Cussac V, Denis G, Walter-Petrich A, Burroni B, Jézéquel N, Giraudier S, Lippert E, Socié G, Kiladjian JJ, Ugo V. Luque Paz D, et al. Among authors: murati a. Blood Adv. 2021 Mar 9;5(5):1442-1451. doi: 10.1182/bloodadvances.2020003444. Blood Adv. 2021. PMID: 33666653 Free PMC article.
53 results